Does a Gradient-Adjusted Cardiac Power Index Improve Prediction of Post-Transcatheter Aortic Valve Replacement Survival Over Cardiac Power Index?

被引:4
作者
Agasthi, Pradyumna [1 ]
Pujari, Sai Harika [1 ]
Mookadam, Farouk [1 ]
Tseng, Andrew S. [2 ]
Venepally, Nithin R. [1 ]
Wang, Panwen [3 ]
Allam, Mohamed [1 ]
Sweeney, John [1 ]
Eleid, Mackram [2 ]
Fortuin, Floyd David [1 ]
Holmes, David R. Jr Jr [2 ]
Beohar, Nirat [4 ]
Arsanjani, Reza [1 ]
机构
[1] Mayo Clin Arizona, Dept Cardiovasc Dis, 5777 E Mayo Blvd, Phoenix, AZ 85054 USA
[2] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN USA
[3] Mayo Clin Arizona, Dept Hlth Sci Res, Scottsdale, AZ USA
[4] Columbia Univ, Div Cardiol, Mt Sinai Med Ctr, Miami Beach, FL USA
关键词
Aortic valve stenosis; transcatheter aortic valve replacement; hemodynamics; mortality; AMERICAN SOCIETY; ECHOCARDIOGRAPHIC-ASSESSMENT; EUROPEAN ASSOCIATION; CARDIOGENIC-SHOCK; HEART-FAILURE; PEAK EXERCISE; PROGNOSIS; RECOMMENDATIONS; OUTPUT; MORTALITY;
D O I
10.3349/ymj.2020.61.6.482
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Cardiac power (CP) index is a product of mean arterial pressure (MAP) and cardiac output (CO). In aortic stenosis, however, MAP is not reflective of true left ventricular (LV) afterload. We evaluated the utility of a gradient-adjusted CP (GCP) index in predicting survival after transcatheter aortic valve replacement (TAVR), compared to CP alone. Materials and Methods: We included 975 patients who underwent TAVR with 1 year of follow-up. CP was calculated as (COxMAP)/[45]xbody surface area (BSA)] (W/m(2)). GCP was calculated using augmented MAP by adding aortic valve mean gradient (AVMG) to systolic blood pressure (CP1), adding aortic valve maximal instantaneous gradient to systolic blood pressure (CP2), and adding AVMG to MAP (CP3). A multivariate Cox regression analysis was performed adjusting for baseline covariates. Receiver operator curves (ROC) for CP and GCP were calculated to predict survival after TAVR. Results: The mortality rate at 1 year was 16%. The mean age and AVMG of the survivors were 81 +/- 9 years and 43 +/- 4 mm Hg versus 80 +/- 9 years and 42 +/- 13 mm fig in the deceased group. The proportions of female patients were similar in both groups (p=0.7). Both CP and GCP were independently associated with survival at 1 year The area under ROCs for CP, CP1, CP2, and CP3 were 0.67 [95% confidence interval (CI), 0.62-0.72], 0.65 (95% CI, 0.60-0.70), 0.66 (95% CI, 0.61-0.71), and 0.63 (95% CI 0.58-0.68), respectively. Conclusion: GCP did not improve the accuracy of predicting survival post TAVR at 1 year, compared to CP alone.
引用
收藏
页码:482 / 491
页数:10
相关论文
共 26 条
[1]  
Agasthi P, 2020, J INVASIVE CARDIOL, V32, P129
[2]   Echocardiographic Assessment of Valve Stenosis: EAE/ASE Recommendations for Clinical Practice [J].
Baumgartner, Helmut ;
Hung, Judy ;
Bermejo, Javier ;
Chambers, John B. ;
Evangelista, Arturo ;
Griffin, Brian P. ;
Iung, Bernard ;
Otto, Catherine M. ;
Pellikka, Patricia A. ;
Quinones, Miguel .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2009, 22 (01) :1-23
[3]   The STS-ACC Transcatheter Valve Therapy National Registry A New Partnership and Infrastructure for the Introduction and Surveillance of Medical Devices and Therapies [J].
Carroll, John D. ;
Edwards, Fred H. ;
Marinac-Dabic, Danica ;
Brindis, Ralph G. ;
Grover, Frederick L. ;
Peterson, Eric D. ;
Tuzcu, E. Murat ;
Shahian, David M. ;
Rumsfeld, John S. ;
Shewan, Cynthia M. ;
Hewitt, Kathleen ;
Holmes, David R., Jr. ;
Mack, Michael J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (11) :1026-1034
[4]   A non-invasively determined surrogate of cardiac power ('circulatory power') at peak exercise is a powerful prognostic factor in chronic heart failure [J].
Cohen-Solal, A ;
Tabet, JY ;
Logeart, D ;
Bourgoin, P ;
Tokmakova, M ;
Dahan, M .
EUROPEAN HEART JOURNAL, 2002, 23 (10) :806-814
[5]   An application of changepoint methods in studying the effect of age on survival in breast cancer [J].
Contal, C ;
O'Quigley, J .
COMPUTATIONAL STATISTICS & DATA ANALYSIS, 1999, 30 (03) :253-270
[6]   The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure [J].
Cotter, G ;
Moshkovitz, Y ;
Kaluski, E ;
Milo, O ;
Nobikov, Y ;
Schneeweiss, A ;
Krakover, R ;
Vered, Z .
EUROPEAN JOURNAL OF HEART FAILURE, 2003, 5 (04) :443-451
[7]   Role of cardiac power in heart failure [J].
Cotter, G ;
Williams, SG ;
Vered, Z ;
Tan, LB .
CURRENT OPINION IN CARDIOLOGY, 2003, 18 (03) :215-222
[8]   Acute heart failure: a novel approach to its pathogenesis and treatment [J].
Cotter, G ;
Moshkovitz, Y ;
Milovanov, O ;
Salah, A ;
Blatt, A ;
Krakover, R ;
Vered, Z ;
Kaluski, E .
EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (03) :227-234
[9]   Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry [J].
Fincke, R ;
Hochman, JS ;
Lowe, AM ;
Menon, V ;
Slater, JN ;
Webb, JG ;
LeJemtel, TH ;
Cotter, G .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (02) :340-348
[10]   Prognostic role of cardiac power index in ambulatory patients with advanced heart failure [J].
Grodin, Justin L. ;
Mullens, Wilfried ;
Dupont, Matthias ;
Wu, Yuping ;
Taylor, David O. ;
Starling, Randall C. ;
Tang, W. H. Wilson .
EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (07) :689-696